4 not yet recruiting, 1 completed, 1 unknown. 4 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Not yet recruiting 3, Completed 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow MDR-001: new trials by email Literature Review of MDR-001 trials Research Report on MDR-001
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment MDR-001 - Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B), Hepatic Insufficiency (MeSH ID: D048550) | Phase 1 | Not yet recruiting | MindRank AI Ltd | 32 | 2026-06-01 | 2026-04-24 |
| Drug-Drug Interaction Study of MDR-001 With Rifampin and Itraconazole in Healthy Adult Participants MDR-001, Rifampin, Itraconazole - Healthy Volunteers (HV) | Phase 1 | Not yet recruiting | MindRank AI Ltd | 28 | 2026-05-06 | 2026-04-24 |
| A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE） MDR-001, Placebo - Overweight or Obesity | Phase 3 | Not yet recruiting | MindRank AI Ltd | 738 | 2026-02-01 | 2025-12-22 |
| Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or Overweight MDR-001, Placebo - Obesity &Amp; Overweight | Phase 1 | Not yet recruiting | MindRank AI Ltd | 24 | 2025-08-09 | 2025-08-08 |
| A Study to Evaluate the Efficacy and Safety of MDR-001 in Subjects Who Are Obesity or Overweight MDR-001, Placebo - Obesity, Overweight and Obesity | Phase 2 | Unknown | MindRank AI Ltd | 300 | 2024-09-23 | 2024-09-24 |
| A Phase I/IIa Clinical Study to Assess the Single and Multiple Ascending Doses of MDR-001 Tablets in Healthy Participants and Obese/ Overweight Participants MDR-001, palcebo - Overweight and Obese Volunteers | Phase 1 / Phase 2 | Completed | MindRank AI Ltd | 128 | 2023-06-09 | 2026-09-18 |
Overweight (4) · Obesity (3) · Hepatic Insufficiency (1) · Lymphoma, Follicular (1)
MindRank AI Ltd (6)
China (6)
Hong Zhang, MD (1) · Xiaojiao Li, MD (1)